Marina Schena

966 total citations
28 papers, 757 citations indexed

About

Marina Schena is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marina Schena has authored 28 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Marina Schena's work include Receptor Mechanisms and Signaling (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Marina Schena is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Marina Schena collaborates with scholars based in Italy, Belgium and Switzerland. Marina Schena's co-authors include Paolo Garzino‐Demo, Monica Rampino, Massimo Fasolis, Libero Ciuffreda, Guglielmo Ramieri, Antonio Dell’Acqua, Sid Berrone, Marco H. Terra, Paola Dalmasso and Alberto Rícci and has published in prestigious journals such as Journal of Clinical Oncology, Hypertension and European Journal of Immunology.

In The Last Decade

Marina Schena

27 papers receiving 747 citations

Peers

Marina Schena
Marina Schena
Citations per year, relative to Marina Schena Marina Schena (= 1×) peers Yanjun Wang

Countries citing papers authored by Marina Schena

Since Specialization
Citations

This map shows the geographic impact of Marina Schena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Schena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Schena more than expected).

Fields of papers citing papers by Marina Schena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Schena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Schena. The network helps show where Marina Schena may publish in the future.

Co-authorship network of co-authors of Marina Schena

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Schena. A scholar is included among the top collaborators of Marina Schena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Schena. Marina Schena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ponzetti, Agostino, Sara Trova, Alessandra Malossi, et al.. (2023). Multiomic analysis of HER2-enriched and AR-positive breast carcinoma with apocrine differentiation and an oligometastatic course: a case report. Frontiers in Oncology. 13. 1240865–1240865.
2.
Indini, Alice, Graziella Pinotti, Fabrizio Artioli, et al.. (2021). Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave. European Journal of Cancer. 148. 112–116. 6 indexed citations
3.
Pellegrino, Benedetta, Chiara Tommasi, Antonino Musolino, et al.. (2021). A review of immune checkpoint blockade in breast cancer. Seminars in Oncology. 48(3). 208–225. 14 indexed citations
4.
Porcu, Michele, Cinzia Solinas, Cristina Migali, et al.. (2020). Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review. Targeted Oncology. 15(1). 25–35. 31 indexed citations
5.
Franco, Pierfrancesco, Monica Rampino, Marina Schena, et al.. (2017). Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients. Medical Oncology. 34(2). 30–30. 13 indexed citations
6.
Moretto, Francesco, Monica Rampino, Fernando Muñoz, et al.. (2014). Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment. La radiologia medica. 119(8). 634–641. 23 indexed citations
7.
Novarino, Anna, Maria Antonietta Satolli, Isabella Chiappino, et al.. (2012). FOLFOX-4 Regimen or Single-agent Gemcitabine as First-line Chemotherapy in Advanced Biliary Tract Cancer. American Journal of Clinical Oncology. 36(5). 466–471. 11 indexed citations
8.
Schena, Marina, Simonetta Guarrera, L Buffoni, et al.. (2012). DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients. DNA repair. 11(4). 374–380. 29 indexed citations
9.
Schena, Marina, Sara Bustreo, C. Barone, et al.. (2012). Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study.. PubMed. 98(4). 451–7. 5 indexed citations
10.
Asioli, Sofia, Francesca Maletta, Ludovica Verdun di Cantogno, et al.. (2012). Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. Human Pathology. 43(11). 2070–2079. 27 indexed citations
11.
Finocchiaro, Concetta, Maurizio Fadda, Taira Monge, et al.. (2011). Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. British Journal Of Nutrition. 108(2). 327–333. 102 indexed citations
12.
Rittà, Massimo, Marco De Andrea, Michele Mondini, et al.. (2008). Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head & Neck. 31(3). 318–327. 56 indexed citations
13.
Daniele, Lorenzo, C. Barone, Anna Sapino, et al.. (2008). Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?. Lung Cancer. 61(1). 73–81. 21 indexed citations
14.
Buffoni, L, C. Barone, Davide Ottaviani, et al.. (2006). Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial. Lung Cancer. 54(3). 353–357. 6 indexed citations
15.
Garzino‐Demo, Paolo, Antonio Dell’Acqua, Paola Dalmasso, et al.. (2006). Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma. Journal of Cranio-Maxillofacial Surgery. 34(6). 344–350. 104 indexed citations
16.
Rícci, Alberto, Elena Bronzetti, Paolo Mulatero, et al.. (1997). Dopamine D 3 Receptor in Peripheral Mononuclear Cells of Essential Hypertensives. Hypertension. 30(6). 1566–1571. 11 indexed citations
17.
Rícci, Alberto, L Chiandussi, Marina Schena, et al.. (1995). Dopamine D5Receptor Expression is Unchanged in Peripheral Blood Lymphocytes in Essential Hypertension. Clinical and Experimental Hypertension. 17(8). 1157–1172. 6 indexed citations
18.
Amenta, Francesco, et al.. (1994). Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex. European Journal of Endocrinology. 131(1). 91–96. 18 indexed citations
19.
Schena, Marina, Daniela Gottardi, Paolo Ghia, et al.. (1993). The Role of Bcl-2 in the Pathogenesis of B Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 11(3-4). 173–179. 30 indexed citations
20.
Bergui, L, L Tesio, Marina Schena, et al.. (1988). CDS and CD21 molecules are a functional unit in the cell/substrate adhesion of B‐chronic lymphocytic leukemia cells. European Journal of Immunology. 18(1). 89–96. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026